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Diabetic Nephropathy S5cellular process, physiological process and metabolism by using Gene
Ontology (GO). The pathway analysis was performed by KEGG, and 135 path-
ways were found significantly altered in the TSF group. The top pathways
mainly included tight junction, Wnt signaling pathway, Drug metabolism-cy-
tochrome P450, MAPK signaling pathway and TGF-beta signaling pathway.
Conclusion: Thus, the current study revealed that TSF might improve kidney
injury type 2 DN by multiple signaling pathways.http://dx.doi.org/10.1016/j.hkjn.2015.08.017
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Objectives: AMP-activated protein kinase (AMPK), which regulates whole-
body energy metabolism and has emerged an attractive target metabolism
syndrome, especially on lipid metabolic disorder in type 2 diabetes. To eval-
uate the role of Tangshen Formular (TSF) in regulating liver dyslipidemia in
diabetes, db/db mice were randomized to a standard diet (SD) or SD plus TSF
for 12 weeks and db/m mice as a control.
Methods and results: we demonstrated that TSF significant suppressed mice
weight gain and liver steatosis with lipid accumulation (Oil Red O &HE stain-
ing results). These changes were accompanied by modulation of insulin and
AMPK/SREBP signaling. The administration of TSF increased the phosphoryla-
tion of AMPK and decreased SREBP-1 nuclear translocation. Moreover, the
target genes of SREBP-1 such as FAS, ACC, and SCD1, at both mRNA and pro-
tein levels were also decreased in mouse received TSF. TSF also potently
inhibited de novo lipogenesis and stimulated fatty acid combustion in mice
liver with downregulation of hepatic gluconeogenesis/lipogenesis genes
(PGC-1a, Acadm, Acox1).
Conclusion: TSF may be a potential promising theraputic approach to atten-
uate fatty liver, dyslipidemia and obesity-related diseases.http://dx.doi.org/10.1016/j.hkjn.2015.08.018
0076
C-Reactive Protein Exacerbates Diabetic Kidney Fibrosis by Enhancing
CD32-Smad3-mTOR Signaling in Human CRP-Tg/db/db Mice
Yong K. You1,2, Xiao R. Huang1, Hai Y. Chen1, Bi H. Xu1, Hua F. Liu2, Hui
Y. Lan1
1Department of Medicine and Therapeutics, Li Ka Shing Institute of Health
Sciences, CUHK Shenzhen Research Institute, The Chinese University of
Hong Kong, Hong Kong, China
2Institute of Nephrology, Guangdong Medical College, Zhanjiang, China
Objective: Type 2 diabetic kidney disease is a leading cause of end-stage
renal failure. Emerging evidence shows that patients with type-2 diabetic
nephropathy (T2DN) is highly correlated with elevated serum levels of C-
reactive protein (CRP). In this study, we hypothesized that CRP may be path-
ogenic and promote T2DN in a novel mouse model of db/db mice with over-
expressing human CRP gene (CRPtg-db/db).
Methods: Human CRPtg-db/db mice and their littermate controls including
db/db, db/m and CRPtg-db/m mice were generated by crossing db/m mouse
with CRPtg mouse that expresses human CRP. Fasting blood glucose, body
weight, blood pressure and 24-h urine microalbumin levels were measured
every 4 weeks over the 36-week period and renal fibrosis was examined at
36 weeks. In addition, signaling mechanisms of CRP-mediated DN was inves-
tigated in vivo and in vitro.
Results: Compared with littermate db/db mice, CRPtg-db/db mice devel-
oped higher blood glucose with more severe diabetic kidney injury including:
a marked increase in microalbuminuria and deposition of collagen I, IV and
connective tissue growth factor (CTGF) within the diabetic kidney. Exacer-
bation of renal fibrosis in CRPtg-db/db mice was associated with a marked
activation of TGF-b/Smad3 and mTOR signaling. Further studies in cultured
HK-2 cells revealed that addition of CRP induces activation of Smad3 through
its receptor CD32b via both TGF-b-dependent mechanism and ERK/P38 MAPK
signaling. Activated Smad3 then bound directly to mTOR and stimulatedfibrosis, which was blocked by an anti-CD32b neutralizing antibody or by
an mTOR inhibitor (rapamycin).
Conclusion: CRP is pathogenic and exacerbates diabetic kidney fibrosis in a
mouse model of T2DN. CRP may promote T2DN via the CD32b-Smad3-mTOR
signaling pathway.http://dx.doi.org/10.1016/j.hkjn.2015.08.019
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Objective: Autophagy attenuates glomerular damage through protection of
glucose-induced podocyte injury but its role in diabetic tubules remains un-
clear. Glucose produces oxidative stress and causes mitochondrial fragmen-
tation in renal tubules. However, information on the interplay between
autophagy and mitochondrial morphogenesis in diabetic tubules is limited.
This study aimed to examine the crosstalk between these two mechanisms
in diabetic tubulopathy.
Methods: Diabetic mice were induced by high fat high sucrose (HFHS) diet.
H&E stain was used to illustrate diabetic tubulopathy. Renal tubular cell
(HK2) culture models were used to investigate the regulating mechanisms
of autophagy on mitochondrial morphology. Transmission electron micro-
scope (TEM) was used to demonstrate autophagosome formation. Western
blot and flow cytometry were used to assay the LC3B-II expressions. Pharma-
cology inhibition and RNAi were used to investigate the role of autophagy in
HK2 cells cultured in the presence or absence of glucose. Mitochondrial
morphology were stained by mitotracker and analyzed by confocal micro-
scopy. TUNEL assay was used to examine the cellular apoptosis in glucose-
treated HK2 cells.
